Phase 4
Completed N=30
Benzocaine Versus Placebo Spray for Pain Relief at Hysterosalpingogram
Pain Relief · Analgesia
Source: ClinicalTrials.gov NCT01925469 ↗
Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Apr 2017
Primary outcomePrimary: Change in Pain Score — 50.6; 70.4 mm — p=0.43
◆ Published Evidence
Emerging
▲ Trending
7citations · ~1 / year
Randomized controlled trial of benzocaine versus placebo spray for pain relief at hysterosalpingogram.
Summary
The objective of this study is to assess the utility of benzocaine spray versus a placebo spray in alleviating pain during and after hysterosalpingogram (HSG).
Linked Publications
-
Randomized controlled trial of benzocaine versus placebo spray for pain relief at hysterosalpingogram.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Pain Score |
50.6; 70.4 | 0.43 |
| SECONDARY Patient Satisfaction |
10; 10; 2; 4; 2; 0 | 0.4 |
| SECONDARY Change in Pain Score From Pre-procedure to 5 Minutes Post Procedure. |
-11.1; -37 | 0.33 |
Eligibility Criteria
Inclusion Criteria
- All women who present to Penn Fertility Care over the age of 18 years old
Exclusion Criteria
- Patients under the age of 18
- Pregnant patients
- Patients with a history of hypersensitivity to benzocaine
- Patients with a history of asthma or bronchitis
Data sourced from ClinicalTrials.gov (NCT01925469) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.